1. Home
  2. Bills
  3. H.R. 8662

H.R. 8662 · 116th Congress · 2019–2020

Accelerating Access to Critical Therapies for ALS Act

H.R. 8662 in the 116th Congress (2019–2020) was introduced on Oct 23, 2020, sponsored by Jeff Fortenberry with 278 co-sponsors.

During the 116th Congress (2019–2020), Donald Trump was president, and Democrats held the House majority and Republicans the Senate majority.

Status
Introduced
Introduced
Oct 23, 2020
Co-sponsors
278
Policy area
Health

What it does

Accelerating Access to Critical Therapies for ALS Act This bill establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions.

Summary by the nonpartisan Congressional Research Service.

Sponsor

Jeff Fortenberry (R-NE). Co-sponsors: 162 Democrats, 116 Republicans.

Where it stands

  • IntroducedOct 23, 2020
  • Passed the House—
  • Passed the Senate—
  • Sent to the President—
  • Became law—

Latest action: Referred to the House Committee on Energy and Commerce. (Oct 23, 2020)

More bills from Jeff Fortenberry in the 116th Congress

Other Health bills in the 116th Congress

Committees

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “H.R. 8662 (116th Congress): Accelerating Access to Critical…,” https://www.capitolreceipts.com/bill/116-hr-8662/accelerating-access-to-critical-therapies-for-als-act (accessed 2026-10-16).

Open the interactive version ›